Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Intra-Cellular Ther (NQ: ITCI ) 73.28 +1.02 (+1.41%) Streaming Delayed Price Updated: 4:00 PM EDT, Aug 30, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Intra-Cellular Ther < Previous 1 2 3 4 5 Next > Intra-Cellular Therapies Inc. (ITCI): The Winning Streak Continues February 16, 2022 Via Investor Brand Network Intra-Cellular Therapies Inc. (ITCI): The Winning Streak Continues February 16, 2022 Via Investor Brand Network Benzinga's Top Ratings Upgrades, Downgrades For February 16, 2022 February 16, 2022 Upgrades According to Compass Point, the prior rating for Comerica Inc (NYSE:CMA) was changed from Neutral to Buy. Comerica earned $1.66 in the fourth quarter, compared to $1.49... Via Benzinga New Psychedelics ETF Launches On NYSE Arca February 02, 2022 Elemental Advisors Inc. has launched its first ETF, composed of companies involved in research, development, production or use of psychedelics to address medical conditions. The PSYK ETF (NYSE: PSYK)... Via Benzinga Analyst Ratings For Intra-Cellular Therapies December 20, 2021 Within the last quarter, Intra-Cellular Therapies (NASDAQ:ITCI) has observe... Via Benzinga 53 Biggest Movers From Friday January 24, 2022 Gainers Blue Star Foods Corp. (NASDAQ: BSFC) shares climbed 100% to close at $3.80 on Friday after gaining around 9% on Thursday. Dave Inc. (NASDAQ: DAVE) jumped 30.3% to settle... Via Benzinga 12 Health Care Stocks Moving In Friday's Intraday Session January 21, 2022 Gainers Biophytis (NASDAQ:BPTS) shares rose 12.3% to $5.28 during Friday's regular session. The market value of their outstanding shares is at $68.0 million. Intra-... Via Benzinga 34 Stocks Moving In Friday's Mid-Day Session January 21, 2022 Gainers Blue Star Foods Corp. (NASDAQ: BSFC) shares jumped 180% to $5.32 after gaining around 9% on Thursday. Bon Natural Life Limited (NASDAQ: BON) shares gained 22% to $3.91.... Via Benzinga 45 Biggest Movers From Yesterday January 05, 2022 Gainers ATA Creativity Global (NASDAQ: AACG) gained 114.3% to close at $2.55. Hoth Therapeutics, Inc. (NASDAQ: HOTH) surged 85.7% to settle at $1.30 after the company announced... Via Benzinga 12 Health Care Stocks Moving In Tuesday's Intraday Session January 04, 2022 Gainers Hoth Therapeutics (NASDAQ: Via Benzinga 34 Stocks Moving In Tuesday's Mid-Day Session January 04, 2022 Gainers TherapeuticsMD, Inc. (NASDAQ: TXMD) jumped 31.7% to $0.5185 after it announced that the FDA approved a low dose version of Bijuva, an oral hormone therapy to treat women... Via Benzinga 12 Health Care Stocks Moving In Tuesday's Pre-Market Session January 04, 2022 Gainers Plus Therapeutics (NASDAQ:PSTV) shares increased by 68.7% to $1.84 during Tuesday's pre-market session. The market value of their outstanding shares is at $28.... Via Benzinga 23 Stocks Moving in Tuesday's Pre-Market Session January 04, 2022 Gainers Allena Pharmaceuticals, Inc. (NASDAQ: ALNA) rose 62.1% to $1.05 in pre-market trading as the company issued a clinical and corporate update. NeuroBo Pharmaceuticals, Inc... Via Benzinga IntraCellular Seeks To Raise $400M Via Equity To Fund Commercialization Of Schizophrenia Med January 04, 2022 Intra-Cellular Therapies Inc (NASDAQ: ITCI) commenced an underwritten public offering of $400 million of shares. Underwriters have an option to purchase up to an... Via Benzinga A Peek Into The Markets: US Stock Futures Up Ahead Of Manufacturing Report January 04, 2022 Pre-open movers U.S. stock futures traded higher in early pre-market trade after the Dow Jones and S&P 500 closed at fresh highs on the first trading day of new year.... Via Benzinga 5 Stocks To Watch For January 4, 2022 January 04, 2022 Some of the stocks that may grab investor focus today are: Wall Street expects SMART Global Holdings, Inc. (NASDAQ: SGH) to report quarterly earnings at $2.00 per share on... Via Benzinga 12 Health Care Stocks Moving In Monday's After-Market Session January 03, 2022 Gainers Indaptus Therapeutics (NASDAQ:INDP Via Benzinga The Global Breast Cancer Treatment Market Expected To Reach $34.06 Billion By End Of 2026 December 21, 2021 Palm Beach, FL – December 21, 2021 – FinancialNewsMedia.com News Commentary – Breast cancer is cancer that develops in the breast tissue. Breast cancer signs include the formation of a lump in the... Via FinancialNewsMedia 65 Biggest Movers From Yesterday December 21, 2021 Gainers Society Pass Incorporated (NASDAQ: SOPA) shares climbed 240.2% to close at $11.26 on Monday after the company reported addition to the Russell 2000 Index. Bluerock... Via Benzinga 38 Stocks Moving In Monday's Mid-Day Session December 20, 2021 Gainers Society Pass Incorporated (NASDAQ: SOPA) shares jumped 120.9% to $7.31 after the company reported addition to the Russell 2000 Index. Can-Fite BioPharma Ltd. (NYSE: CANF... Via Benzinga FDA Approves Intra-Cellular's Antipsychotic For Bipolar Depression December 20, 2021 The FDA has approved Intra-Cellular Therapies Inc (NASDAQ: ITCI) Caplyta for depressive episodes associated with bipolar I or II disorder in adults. The approval... Via Benzinga 12 Health Care Stocks Moving In Monday's Pre-Market Session December 20, 2021 Gainers Intra-Cellular Therapies (NASDAQ:ITCI) stock rose 18.79% to $46.52 during Monday's pre-market session. The market value of their outstanding shares is at $3.7... Via Benzinga Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday December 20, 2021 The weekend break is over and that means it's time to get back to work with the biggest pre-market stock movers for Monday! Via InvestorPlace The Daily Biotech Pulse: Genfit Spikes On Liver Disease Drug Licensing Deal, Lyell Gets Nod For Solid Tumor Study, Decision-Day For Intra-Cellular, Argenx December 17, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Stocks In Focus Merck Announces Publication Of Positive Data From Late-Stage Study Of Oral... Via Benzinga The Week Ahead In Biotech (Dec. 12-18): Hematology Conference Presentations, FDA Decisions For Calliditas, Argenx, Intra-Cellular & Eagle Pharma And More December 12, 2021 Biotech stocks closed out the week ending Dec. 10 with modest losses as investors moved money out of defensives and into risky bets amid the broader market rebound. Multiple... Via Benzinga Exposures Product Safety Attention Biotech Investors: Mark Your Calendar For December PDUFA Dates December 02, 2021 A majority of verdicts handed down by the FDA in November were positive. Three new molecular entities were approved during the month, taking the total number of NME approvals for... Via Benzinga Exposures Product Safety Looking Into Intra-Cellular Therapies's Return On Capital Employed November 10, 2021 Benzinga Pro data, Intra-Cellular Therapies (NASDAQ:ITCI) reported Q3 sales of $22.21 million. Earnings fell to a loss of $77.32 million, resulting in a 11.83% decrease from last... Via Benzinga Intra-Cellular Therapies inc (ITCI) Q3 2021 Earnings Call Transcript November 09, 2021 ITCI earnings call for the period ending September 30, 2021. Via The Motley Fool Topics Earnings Exposures Financial Intra-Cellular Therapies: Q3 Earnings Insights November 09, 2021 Intra-Cellular Therapies (NASDAQ:ITCI) reported its Q3 earnings results on Tuesday, November 9, 2021 at 08:00 AM. Here's what investors need to know about the... Via Benzinga Two Trillion-Dollar Industries Being Transformed By Tech October 20, 2021 FN Media Group Presents Oilprice.com Market Commentary London – October 20, 2021 – Big money is pouring into two disruptive segments in two of the world’s biggest industries – healthcare and energy.... Via FinancialNewsMedia < Previous 1 2 3 4 5 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.